Counts of positive, neutral, and negative news items. Not a price chart.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
The items moving the net sentiment the most, by direction and influence.
Pakistan Pharma Association Warns on Drug Price Deregulation Reversal: Pharma Stocks Face Headwinds
Drug pricing (DRAP) · High influence · Long term
Drug Pricing Deadlock Causes Shortages: Pharmaceutical Stocks Face Headwinds
Drug pricing (DRAP) · High influence · Long term
FY27 Budget Continues Tariff Reforms: Auto, Pharma, Steel, Chemical Stocks See Input Cost Relief
Budget taxation (GST/FED/duties) · Medium influence · Long term
Barcode System on Medicines and Pak-China Pharma Conference: Positive for Pharma Stocks
Direct news · Medium influence · Long term
Punjab's Rs18.5 Billion Free Treatment Program Boosts Pharmaceutical Sector
Consumer demand & purchasing power · Medium influence · Long term
Macro, commodity, FX and regulatory forces that moved ABOT in this range, with the stories behind each.
Sign up free to track ABOT, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.
Track ABOT for freeInformational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Soaring Drug Prices in KP: Positive for Pakistan Pharma Stocks
Also monitored for ABOT (no news in this range): Import restrictions / LC curbs.
How news sentiment on Abbott Laboratories Pakistan (ABOT) has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.
